Related Experiment Videos
Mitochondrial abnormalities and peripheral neuropathy in inflammatory myopathy, especially inclusion body myositis
1Institut für Neuropathologie, Universitätsklinikum der RWTH Aachen, Germany.
Abstract:
Computer retrieval in a database, comprising 7,225 muscle cases, revealed that mitochondrial myopathies do not occur more frequently in inflammatory myopathies (3.74%) than in the whole series (3.69%). A more detailed study of inclusion body myositis (IBM), however, showed that severe mitochondrial alterations were apparent in about twice as many IBM cases as expected. This confirms recent studies of others although a causal relationship has thus far not been established. Identification of mitochondrial deletions by Southern blotting corresponded to the presence of severe structural abnormalities of mitochondria. Peripheral neuropathy of variable severity was noted in all cases of IBM and mitochondrial myopathy. By contrast, the association of severe mitochondrial abnormalities with polymyositis, systemic scleroderma, and vasculitis observed in some cases of the present series may be incidental or age dependent.
Insights
Mitochondrial myopathies are not more common in inflammatory myopathies. However, inclusion body myositis (IBM) shows significantly more severe mitochondrial changes, suggesting a potential link needing further research.
Area of Science:
- Neurology
- Mitochondrial Diseases
- Muscle Disorders
Background:
- Mitochondrial myopathies are a group of neuromuscular disorders.
- The prevalence of mitochondrial myopathies in inflammatory myopathies is not well-established.
- Inclusion body myositis (IBM) is a specific type of inflammatory myopathy.
Purpose of the Study:
- To determine the frequency of mitochondrial myopathies in inflammatory myopathies.
- To investigate the association between mitochondrial alterations and inclusion body myositis (IBM).
- To explore the relationship between mitochondrial deletions, structural abnormalities, and clinical presentation.
Main Methods:
- Database retrieval of 7,225 muscle cases.
- Comparative analysis of mitochondrial myopathy frequency in inflammatory myopathies versus the general series.
- Detailed study of inclusion body myositis (IBM) cases.
- Southern blotting for identification of mitochondrial deletions.
- Clinical assessment for peripheral neuropathy and association with other rheumatic diseases.
Main Results:
- Mitochondrial myopathies occurred at a similar frequency in inflammatory myopathies (3.74%) and the overall series (3.69%).
- Severe mitochondrial alterations were found in approximately twice the expected number of inclusion body myositis (IBM) cases.
- Mitochondrial deletions correlated with severe structural mitochondrial abnormalities.
- Peripheral neuropathy was present in all IBM and mitochondrial myopathy cases.
- Associations between mitochondrial abnormalities and polymyositis, scleroderma, or vasculitis may be incidental or age-related.
Conclusions:
- Mitochondrial myopathies are not disproportionately represented in inflammatory myopathies.
- Inclusion body myositis (IBM) exhibits a higher prevalence of severe mitochondrial alterations, warranting further investigation into a potential causal link.
- Mitochondrial deletions are associated with structural mitochondrial damage.
- Peripheral neuropathy is a common feature in IBM and mitochondrial myopathy.
- The link between mitochondrial abnormalities and other systemic conditions in IBM requires more study.